Collegium Pharmaceutical (COLL) Inventory Average (2016 - 2026)

Collegium Pharmaceutical's Inventory Average history runs 11 years deep, the most recent figure standing at $41.8 million for Q1 2026.

• In Q1 2026, Inventory Average rose 14.94% year-over-year to $41.8 million; the TTM figure through Mar 2026 stood at $41.8 million (up 14.94% YoY), while the FY2025 annual figure was $38.2 million, up 12.64% from the prior year.
• Inventory Average was $41.8 million for Q1 2026 at Collegium Pharmaceutical, up from $39.5 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $79.0 million in Q2 2022 to a low of $29.5 million in Q2 2023.
• Historically, Inventory Average has averaged $41.9 million across 5 years, with a median of $37.7 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Inventory Average jumped 349.99% in 2022, then slumped 62.69% in 2023.
• A 5-year view of Inventory Average shows it stood at $55.6 million in 2022, then plunged by 40.21% to $33.2 million in 2023, then increased by 10.74% to $36.8 million in 2024, then gained by 7.3% to $39.5 million in 2025, then advanced by 5.94% to $41.8 million in 2026.
• The last three Inventory Average figures came in at $41.8 million (Q1 2026), $39.5 million (Q4 2025), and $38.1 million (Q3 2025), per Business Quant data.